Subscribe to RSS - ResMed

ResMed

In brief: F&P upgrades guidance, NSM creates ‘Chill Spot’

 - 
08/30/2019

IRVINE, Calif. – Fisher & Paykel Healthcare has upgraded its guidance for the financial year ending March 31, 2020, to full operating revenue of about $1.17 billion and net profit after tax of about $245 million to $255 million.

OneTrust tapped by ResMed for compliance

 - 
08/27/2019

ATLANTA – OneTrust has been selected by ResMed, which has more than 10 million cloud-connected devices for daily remote patient monitoring, for global privacy compliance.

ResMed nears settlement of years-long investigation

It was, otherwise, a strong fourth quarter and fiscal year 2019 for the company
 - 
07/26/2019

SAN DIEGO – ResMed divulged a projected $41.2 million hit to its net income in the fourth quarter of fiscal year 2019 to resolve an investigation by the Department of Justice of the company’s resupply program.

ResMed’s revenue hits $2.6B for FY 2019

 - 
07/26/2019

SAN DIEGO – ResMed reported revenue of $705 million for the fourth quarter of fiscal year 2019, a 13% increased compared to the same period last year.

Connected care is a multi-dimensional domain

 - 
07/25/2019

Pinpointing exactly what “connected care” is can be a tricky exercise.

ResMed completes $500M debt offering

 - 
07/16/2019

SAN DIEGO – ResMed has completed a $500 million private placement debt offering, with proceeds used to pay down current borrowings on the company’s senior unsecured revolving credit facility. “We are pleased to complete this U.S.

ResMed cites higher rates of sleep apnea

 - 
06/11/2019

SAN ANTONIO – Roughly 170 million people across North and South America have sleep apnea, according to a study ResMed presented at SLEEP 2019.

ResMed sponsors studies, wins award

 - 
06/07/2019

SAN DIEGO – ResMed will present and/or sponsor 15 abstracts at the SLEEP 2019 conference, June 8-12 in San Antonio. The abstracts highlight the updated prevalence of sleep apnea, and best practices for diagnosing and effectively treating the common chronic disease.

ResMed: ‘We’re only getting started’

 - 
05/31/2019

SAN DIEGO – How much has ResMed grown in the past 30 years? Here’s one way to look at it: The company reported revenues of $1 million for its first fiscal year in 1990; it reported revenues of $662.2 million for the third quarter alone for fiscal year 2019.

ResMed adds exec in South Asia to increase awareness

 - 
05/31/2019

SAN DIEGO – ResMed has appointed Shubhi Khurana as general manager for India and South Asia to create market development and awareness initiatives to educate the public, medical community and decision-makers about the prevalence of sleep and respiratory diseases in the re

Pages